Sign up to save your podcasts
Or
Share With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?
Aldeyra CEO and president Todd Brady shares the podcast mike with Dave McMullin, the former Shire executive who recently joined as senior vice president of corporate development and strategy. Together, the pair discuss the company’s positive Phase II test results for topical ocular reproxalap in patients with dry eye disease. They also speak about Aldeyra’s promising pipeline.
View all episodes
By OIS Podcast
4.6
3232 ratings
Aldeyra CEO and president Todd Brady shares the podcast mike with Dave McMullin, the former Shire executive who recently joined as senior vice president of corporate development and strategy. Together, the pair discuss the company’s positive Phase II test results for topical ocular reproxalap in patients with dry eye disease. They also speak about Aldeyra’s promising pipeline.
More shows like OIS Podcast | Ophthalmology's leading Podcast
View all
Global News Podcast
7,708 Listeners
Ophthalmology off the Grid by Eyetube
43 Listeners
How I Built This with Guy Raz
30,233 Listeners
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,445 Listeners
The Daily
112,942 Listeners
Up First from NPR
56,541 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Indicator from Planet Money
9,533 Listeners
The Journal.
6,065 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Experts InSight
51 Listeners
ACQ2 by Acquired
261 Listeners
Ophthalmology Journal
18 Listeners
Eyewire News: The Podcast
0 Listeners